TWD 32.3
(1.1%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 1.44 Billion TWD | 6.21% |
2022 | 1.36 Billion TWD | 177.51% |
2021 | 491.29 Million TWD | 70.38% |
2020 | 288.35 Million TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 1.44 Billion TWD | 6.21% |
2023 Q4 | 1.44 Billion TWD | 7.2% |
2023 Q2 | 1.35 Billion TWD | -0.92% |
2022 Q4 | 1.36 Billion TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BIONET Corp. | 2.34 Billion TWD | 38.345% |
DIVA Laboratories, Ltd. | 1.24 Billion TWD | -16.427% |
Genetics Generation Advancement Corp. | 595.05 Million TWD | -143.347% |
Welgene Biotech Co.,Ltd. | 548.16 Million TWD | -164.162% |
Puriblood Medical Co., Ltd. | 265.51 Million TWD | -445.377% |